Asset Management One’s Royalty Pharma RPRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $13M | Buy |
270,526
+79,617
| +42% | +$3.49M | 0.04% | 383 |
|
|
2025
Q4 | $7.46M | Sell |
190,909
-17,023
| -8% | -$649K | 0.02% | 538 |
|
|
2025
Q3 | $7.34M | Sell |
207,932
-22,499
| -10% | -$815K | 0.02% | 537 |
|
|
2025
Q2 | $8.3M | Buy |
230,431
+65,500
| +40% | +$2.17M | 0.03% | 488 |
|
|
2025
Q1 | $5.13M | Buy |
164,931
+12,148
| +8% | +$385K | 0.02% | 601 |
|
|
2024
Q4 | $3.9M | Buy |
152,783
+4,427
| +3% | +$117K | 0.01% | 658 |
|
|
2024
Q3 | $4.2M | Buy |
148,356
+5,942
| +4% | +$165K | 0.01% | 639 |
|
|
2024
Q2 | $3.76M | Sell |
142,414
-4,797
| -3% | -$133K | 0.01% | 640 |
|
|
2024
Q1 | $4.47M | Sell |
147,211
-1,143
| -0.8% | -$33.7K | 0.02% | 617 |
|
|
2023
Q4 | $4.15M | Sell |
148,354
-14,664
| -9% | -$403K | 0.02% | 639 |
|
|
2023
Q3 | $4.42M | Sell |
163,018
-479
| -0.3% | -$14.2K | 0.02% | 608 |
|
|
2023
Q2 | $5.03M | Sell |
163,497
-8,311
| -5% | -$281K | 0.02% | 584 |
|
|
2023
Q1 | $6.19M | Buy |
171,808
+37,997
| +28% | +$1.41M | 0.03% | 519 |
|
|
2022
Q4 | $5.29M | Sell |
133,811
-4,859
| -4% | -$203K | 0.03% | 547 |
|
|
2022
Q3 | $5.57M | Buy |
138,670
+5,628
| +4% | +$240K | 0.03% | 513 |
|
|
2022
Q2 | $5.59M | Sell |
133,042
-3,099
| -2% | -$127K | 0.03% | 551 |
|
|
2022
Q1 | $5.3M | Sell |
136,141
-7,220
| -5% | -$284K | 0.02% | 618 |
|
|
2021
Q4 | $5.73M | Buy |
143,361
+70,408
| +97% | +$2.74M | 0.02% | 627 |
|
|
2021
Q3 | $2.64M | Sell |
72,953
-4,798
| -6% | -$186K | 0.01% | 784 |
|
|
2021
Q2 | $3.19M | Sell |
77,751
-2,935
| -4% | -$125K | 0.01% | 772 |
|
|
2021
Q1 | $3.52M | Buy |
80,686
+25,067
| +45% | +$1.19M | 0.01% | 733 |
|
|
2020
Q4 | $2.76M | Buy |
+55,619
| New | +$2.36M | 0.01% | 755 |
|
Other funds holding RPRX
